Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Emergence Delirium in Pediatric Neurosurgery
NCT07046364Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in emergence delirium (ED), sponsored by Peking University First Hospital. Started Jan 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT07046364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07046364.